John E. Kao - 26 Mar 2021 Form 3/A - Amendment Insider Report for Alignment Healthcare, Inc. (ALHC)

Role
Chief Executive Officer, Director
Signature
/s/ Richard A. Cross, as Attorney-in-Fact, for John E. Kao
Issuer symbol
ALHC
Transactions as of
26 Mar 2021
Net transactions value
$0
Form type
3/A - Amendment
Filing time
13 May 2021, 17:22:04 UTC
Date Of Original Report
26 Mar 2021
Next filing
15 Oct 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ALHC Common Stock, par value $0.001 per share ("Common Stock") 4,285,037 26 Mar 2021 See Footnote F1, F2
holding ALHC Common Stock 311,030 26 Mar 2021 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ALHC Stock Option (right to buy) 26 Mar 2021 Common Stock 3,916,668 $18.00 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents 2,797,642 shares of Common Stock of Alignment Healthcare, Inc. (the "Company") and 1,487,395 restricted shares of Common Stock of the Company that will vest upon a change of control of the Company or otherwise (A) if received in exchange for pre-IPO (as defined below) transaction-based incentive units, on the later of (x) the four-year anniversary of the initial vesting date, or (y) 50% on the first anniversary of Company's initial public offering (the "IPO") and 50% on the second anniversary of the IPO, in each case, subject to Mr. Kao's continued employment or service on each such vesting date and (B) if received in exchange for pre-IPO service-based incentive units according to the pre-IPO vesting schedule applicable to Mr. Kao disclosed in the "Executive Compensation - Outstanding Equity Awards at Fiscal Year End" section of the Company's registration statement on Form S-1.
F2 Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.
F3 Represents 311,030 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest 25% on the first four anniversaries of the initial vesting date.
F4 Vest 25% on the first four anniversaries of the initial vesting date.

Remarks:

This Form 3 amends and restates in its entirety the Form 3 filed by Mr. Kao on March 26, 2021. The purpose of this Form 3 is to correct the form of ownership of 311,030 restricted stock units and 3,916,668 stock options which were inadvertently reported as being held indirectly in the original Form 3. Such restricted stock units and stock options are held directly by Mr. Kao. This amendment does not affect Mr. Kao's aggregate beneficial ownership of non-derivative and derivative securities of the Company.